Abstract:OBJECTIVE Given the paucity of data on the natural history of brainstem cavernous malformations (CMs), the authors aimed to evaluate the annual hemorrhage rate and hemorrhagic risk of brainstem CMs. METHODS Nine hundred seventy-nine patients diagnosed with brainstem CMs were referred to Beijing Tiantan Hospital from 2006 to 2015; 224 patients were excluded according to exclusion criteria, and 47 patients were lost to follow-up. Thus, this prospective observational cohort included 708 cases (324 females). All patients were registered, clinical data were recorded, and follow-up was completed. RESULTS Six hundred ninety (97.5%) of the 708 patients had a prior hemorrhage, 514 (72.6%) had hemorrhagic presentation, and developmental venous anomaly (DVA) was observed in 241 cases (34.0%). Two hundred thirty-seven prospective hemorrhages occurred in 175 patients (24.7%) during 3400.2 total patient-years, yielding a prospective annual hemorrhage rate of 7.0% (95% CI 6.2%–7.9%), which decreased to 4.7% after the 1st year. Multivariate Cox regression analysis after adjusting for sex and age identified hemorrhagic presentation (HR 1.574, p = 0.022), DVA (HR 1.678, p = 0.001), mRS score ≥ 2 on admission (HR 1.379, p = 0.044), lesion size > 1.5 cm (HR 1.458, p = 0.026), crossing the axial midpoint (HR 1.446, p = 0.029), and superficially seated location (HR 1.307, p = 0.025) as independent adverse factors for prospective hemorrhage, but history of prior hemorrhage was not significant. The annual hemorrhage rates were 8.3% and 4.3% in patients with and without hemorrhagic presentation, respectively; the rate was 9.9%, 6.0%, and 1.0% in patients with ≥ 2, only 1, and 0 prior hemorrhages, respectively; and the rate was 9.2% in patients with both hemorrhagic presentation and focal neurological deficit on admission. CONCLUSIONS The study reported an annual hemorrhage rate of 7.0% exclusively for brainstem CMs, which significantly increased if patients presented with both hemorrhagic presentation and focal neurological deficit (9.2%), or any other risk factor. Patients with a risk factor for hemorrhage needed close follow-up regardless of the number of prior hemorrhages. It should be noted that the referral bias in this study could have overestimated the annual hemorrhage rate. This study improved the understanding of the natural history of brainstem CMs, and the results are important for helping patients and physicians choose a suitable treatment option based on the risk factors and stratified annual rates. Clinical trial registration no.: ChiCTR-POC-17011575 (http://www.chictr.org.cn/).

Natural course of cerebral and spinal cavernous malformations: a complete ten-year follow-up study

Natural History of Spinal Cord Cavernous Malformations: A Multicenter Cohort Study

Multiple cerebral cavernous malformations: Clinical course of confirmed, assumed and non‐familial disease

Symptomatic Hemorrhage From Cerebral Cavernous Malformations: Evidence from a Cohort Study

Natural history of brainstem cavernous malformations: prospective hemorrhage rate and adverse factors in a consecutive prospective cohort

Neurological outcomes of untreated brainstem cavernous malformations in a prospective observational cohort and literature review

Predictors of future haemorrhage from cerebral cavernous malformations: a retrospective cohort study

Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study

Natural History of Brainstem Cavernous Malformations: On the Variation in Hemorrhage Rates

Early and long-term outcome of surgical versus conservative management for intracranial cerebral cavernous malformation: Meta-analysis of reconstructed time-to-event data

Surgical timing and long-term outcomes in patients with severe haemorrhagic spinal cord cavernous malformations

Comparison of Outcome Between Surgical and Conservative Management of Symptomatic Spinal Cord Cavernous Malformations.

Surgical Outcomes Of Spinal Cord Intramedullary Cavernous Malformation: A Retrospective Study Of 83 Patients In A Single Center Over A 12-Year Period

Overview of cerebral cavernous malformations: comparison of treatment approaches

A systematic review and meta-analysis of surgeries performed for treating deep-seated cerebral cavernous malformations.

Contemporary cohort of cerebral cavernous malformations: natural history and utility of follow-up MRI

Outcomes after surgical and nonsurgical treatment of pediatric cerebral cavernous malformation

Treatment Strategies and Prognostic Factors for Spinal Cavernous Malformation: a Single-Center Retrospective Cohort Study

Clinical features, hemorrhage risk and epilepsy outcomes of familial cerebral cavernous malformation: A 20-year observational pragmatic single-center study

Infratentorial Cerebral Cavernous Malformation May be a Risk Factor for Symptomatic Bleeding and Precocity of Symptoms: A Multicenter, Propensity Score Matched, Case-Control Study

Long-Term Outcomes of Gamma Knife Radiosurgery for Cerebral Cavernous Malformations: 10 Years and Beyond